45 filings
8-K
ONCR
Oncorus, Inc.
3 Aug 23
Departure of Directors or Certain Officers
4:36pm
8-K
ONCR
Oncorus, Inc.
28 Jul 23
Departure of Directors or Certain Officers
4:12pm
8-K
ONCR
Oncorus, Inc.
19 Jul 23
Termination of a Material Definitive Agreement
4:00pm
8-K
ONCR
Oncorus, Inc.
26 Jun 23
Hilco Streambank Seeks Offers to Acquire Patent Portfolio of Biopharmaceutical Company Oncorus
4:01pm
8-K
ONCR
Oncorus, Inc.
9 Jun 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:26pm
8-K
prlk5nh x7gkyocav903
7 Jun 23
Departure of Directors or Certain Officers
4:10pm
8-K
j4pfd7n svm7ftx
1 Jun 23
Oncorus Announces Workforce Reduction Plan
4:34pm
8-K
j2yu2m6r14mow
22 May 23
Oncorus Reports First Quarter 2023 Financial Results and Provides Business Updates
4:13pm
8-K
6f4m7 luysvl45
18 May 23
Termination of a Material Definitive Agreement
4:06pm
8-K
mna2ejq0e0 zs5rks
5 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
5:02pm
8-K
h2b2wx9fd 5bnrbsdlio
1 May 23
Departure of Directors or Certain Officers
6:39am
8-K
w43gvnza5jcc9tba
24 Mar 23
Oncorus Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Updates
7:27am
8-K
ibya 1l9z
14 Mar 23
Regulation FD Disclosure
4:28pm
8-K
g0ts21zwk2 z0
10 Mar 23
Regulation FD Disclosure
5:09pm
8-K
2tnv4
30 Nov 22
Oncorus Announces Portfolio Reprioritization to Focus on IV-Administered, Self-Amplifying RNA Medicines for Patients with Cancer
7:07am
8-K
ae5gdv3fr533mc khak
2 Nov 22
Oncorus Reports Third Quarter 2022 Financial Results and Provides Business Updates
7:11am
8-K
sgjqks8ws
14 Sep 22
Entry into a Material Definitive Agreement
4:34pm
8-K
iikv7jy 936
5 Aug 22
Regulation FD Disclosure
7:10am
8-K
ux0n5
4 Aug 22
Oncorus Reports Second Quarter 2022 Financial Results and Provides Business Updates
9:04am
8-K
l06j1
23 Jun 22
Oncorus Appoints Douglas Fambrough to Board of Directors
7:21am